<DOC>
	<DOCNO>NCT01242072</DOCNO>
	<brief_summary>This open-label study define safety profile maximum tolerate dose confirm clinical effective dose palifosfamide-tris give intravenously combination etoposide carboplatin wide range cancer etoposide carboplatin normally give . Once maximum dose palifosfamide-tris determine , Phase II study use 3 agent combine begin .</brief_summary>
	<brief_title>Intravenous Palifosfamide-tris Combination With Etoposide Carboplatin Patients With Malignancies</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Osteosarcoma</mesh_term>
	<mesh_term>Testicular Neoplasms</mesh_term>
	<mesh_term>Thymoma</mesh_term>
	<mesh_term>Thymus Neoplasms</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Isophosphamide mustard</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<criteria>18 year old great Malignancy schedule receive etoposide carboplatin therapy Eastern Cooperative Oncology Group ( ECOG ) performance 0 1 Adequate bone marrow , liver , renal function coagulation status Informed consent Agree use birth control 28 day last treatment dose Pregnancy test woman childbearing potential No available standard therapy Allergy study treatment drug Unstable current medical condition Presence history injury urinary tract Active infection Major surgery within 4 week prior treatment Minor surgery within 2 week prior treatment Current acute steroid therapy taper Currently pregnant nurse Substance abuse condition may interfere participation Received investigational drug within 30 day Within 4 week last chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>malignancy</keyword>
	<keyword>etoposide carboplatin</keyword>
	<keyword>non small cell lung cancer</keyword>
	<keyword>small cell lung cancer</keyword>
	<keyword>testicular cancer</keyword>
	<keyword>thymoma</keyword>
	<keyword>ovarian cancer</keyword>
	<keyword>osteosarcoma</keyword>
</DOC>